CoChat

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation

Open access
Stefano, Daniela De, Villella, Valeria R, Esposito, Speranza, Tosco, Antonella, Sepe, Angela, Gregorio, Fabiola De, Salvadori, Laura, Grassia, Rosa, Leone, Carlo A, Rosa, Giuseppe De, Maiuri, Maria C, Pettoello-Mantovani, Massimo, Guido, Stefano, Bossi, Anna, Zolin, Anna, Venerando, Andrea, Pinna, Lorenzo A, Mehta, Anil, Bona, Gianni, Kroemer, Guido, Maiuri, Luigi, Raia, Valeria · 2014 · Autophagy
Cited by 148

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Restoration of BECN1/Beclin 1-dependent autophagy and depletion of SQSTM1/p62 by genetic manipulation or autophagy-stimulatory proteostasis regulators, such as cystamine, have positive effects on mouse models of human cystic fibrosis (CF). These measures rescue the functional expression of the most frequent pathogenic CFTR mutant, F508del, at the respiratory epithelial surface and reduce lung inflammation in Cftr(F508del) homozygous mice. Cysteamine, the reduced form of cystamine, is an FDA-approved drug. Here, we report that oral treatment with cysteamine greatly reduces the mortality rate and improves the phenotype of newborn mice bearing the F508del-CFTR mutation. Cysteamine was also able to increase the plasma membrane expression of the F508del-CFTR protein in nasal epithelial cells from F508del homozygous CF patients, and these effects persisted for 24 h after cysteamine withdrawal. Importantly, this cysteamine effect after washout was further sustained by the sequential administration of epigallocatechin gallate (EGCG), a green tea flavonoid, both in vivo, in mice, and in vitro, in primary epithelial cells from CF patients. In a pilot clinical trial involving 10 F508del-CFTR homozygous CF patients, the combination of cysteamine and EGCG restored BECN1, reduced SQSTM1 levels and improved CFTR function from nasal epithelial cells in vivo, correlating with a decrease of chloride concentrations in sweat, as well as with a reduction of the abundance of TNF/TNF-alpha (tumor necrosis factor) and CXCL8 (chemokine [C-X-C motif] ligand 8) transcripts in nasal brushing and TNF and CXCL8 protein levels in the sputum. Altogether, these results suggest that optimal schedules of cysteamine plus EGCG might be used for the treatment of CF caused by the F508del-CFTR mutation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/15548627.2014.973737

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 148

Metadata

Authors
Stefano, D. D., Villella, V. R., Esposito, S., Tosco, A., Sepe, A., Gregorio, F. D., Salvadori, L., Grassia, R., Leone, C. A., Rosa, G. D., Maiuri, M. C., Pettoello-Mantovani, M., Guido, S., Bossi, A., Zolin, A., Venerando, A., Pinna, L. A., Mehta, A., Bona, G., Kroemer, G., Maiuri, L., & Raia, V.
Venue
Autophagy
Published
2014-11-02
Volume
10
Issue
11
Pages
2053-2074
ISSN
  • 1554-8627 (ISSN-L)
  • 1554-8635
OpenAlex
W2147285875
Cited by
148
References
8
FWCI
15.02
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. https://app.cochat.ai/papers/10.4161/15548627.2014.973737
The paper
Stefano, D. D., Villella, V. R., Esposito, S., Tosco, A., Sepe, A., Gregorio, F. D., Salvadori, L., Grassia, R., Leone, C. A., Rosa, G. D., Maiuri, M. C., Pettoello-Mantovani, M., Guido, S., Bossi, A., Zolin, A., Venerando, A., Pinna, L. A., Mehta, A., Bona, G., . . . Raia, V. (2014). Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. Autophagy. https://doi.org/10.4161/15548627.2014.973737

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.